Effect of supplementation in treatment of Congestive Heart Failure

Phase 3

• Conditions: Congestive Heart Failure.; Congestive Heart Failure; I50.0

• Registration Number: IRCT2017053033941N2
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Inclusion Criteria: Subjects diagnosed with CHF
Individuals aged 45-85 years;

Exclusion Criteria

Those consuming Selenium supplements within the past 3 months,
having an acute myocardial infarction within the past 3 months,
having cardiac surgery within the past 3 months
significant renal or hepatic failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.